Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Heerma Peter Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Sold 3,091 shares @ $8.2511, valued at $25.5k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2023 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Sold 1,550 shares @ $21.9044, valued at $34k
10/06/2022 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Sold 3,042 shares @ $25.68, valued at $78.1k
02/02/2022 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Granted 9,840 shares @ $0
Sold 1,125 shares @ $27.4, valued at $30.8k
Granted 39,360 options to buy @ $27.5, valued at $1.1M
Granted 9,840 options to buy @ $0
Granted 8,000 options to buy @ $0
01/26/2022 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Sold 1,875 shares @ $24.98, valued at $46.8k
10/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Sold 1,125 shares @ $31.41, valued at $35.3k
Sold 1,125 shares @ $31.58, valued at $35.5k
02/05/2021 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Granted 4,500 shares @ $0
02/03/2021 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Sold 563 shares @ $30.75, valued at $17.3k
Sold 563 shares @ $28.91, valued at $16.3k
01/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2020 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Retrophin, Inc.
Txns: Sold 2,188 shares @ $18.9, valued at $41.4k
Sold 2,188 shares @ $19.35, valued at $42.3k
01/31/2020 4 Heerma Peter (Chief Commercial Officer) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 9,000 shares @ $0
Granted 55,000 options to buy @ $15.46, valued at $850.3k
Granted 9,000 options to buy @ $0
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy